Wentworth Kory James (CIK 0001725663)

Latest company ownership

TRDA - Entrada Therapeutics, Inc.

Role: CFO

Shares held

110,026

Last filed at

Nov 24, 2025

Confidence Score

37.7

2025Q4

Confidence Score History

2022Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Nov 21, 2025	Nov 24, 2025	Entrada Therapeutics, Inc.	CFO	Sell	32.5	-8,910	-7.49%	✓	$88.9K
Sep 2, 2025	Sep 4, 2025	Entrada Therapeutics, Inc.	CFO	Sell	47.5	-1,734	-1.44%	✗	$9.4K
Mar 17, 2025	Mar 19, 2025	Entrada Therapeutics, Inc.	CFO	Sell	48.8	-1,784	-1.60%	✓	$19K
Mar 1, 2025	Mar 4, 2025	Entrada Therapeutics, Inc.	CFO	Sell	95.0	+37,471	50.74%	✗	$57.6K
Nov 29, 2024	Dec 3, 2024	Entrada Therapeutics, Inc.	CFO	Sell	37.5	-6,000	-3.90%	✓	$119.9K
Nov 11, 2024	Nov 13, 2024	Entrada Therapeutics, Inc.	CFO	Sell	25.0	-8,637	-10.47%	✓	$172.6K
Sep 9, 2024	Sep 10, 2024	Entrada Therapeutics, Inc.	CFO	Sell	41.3	-3,195	-4.01%	✓	$47.8K
Sep 3, 2024	Sep 5, 2024	Entrada Therapeutics, Inc.	CFO	Sell	46.3	-1,731	-2.13%	✗	$27.1K
Jul 8, 2024	Jul 10, 2024	Entrada Therapeutics, Inc.	CFO	Sell	45.0	-1,758	-2.11%	✓	$26.3K
Mar 6, 2024	Mar 8, 2024	Entrada Therapeutics, Inc.	CFO	Sell	32.5	-4,086	-5.22%	✓	$50.3K
Mar 1, 2024	Mar 5, 2024	Entrada Therapeutics, Inc.	CFO	Sell	91.3	+28,685	57.87%	✗	$27.7K
Dec 21, 2023	Dec 26, 2023	Entrada Therapeutics, Inc.	CFO	Sell	32.5	-12,500	-5.83%	✓	$194.8K
Sep 1, 2023	Sep 6, 2023	Entrada Therapeutics, Inc.	CFO	Sell	91.3	+12,824	34.90%	✓	$19K
Jul 10, 2023	Jul 12, 2023	Entrada Therapeutics, Inc.	CFO	Sell	25.0	-10,000	-11.98%	✓	$179.9K
Jun 21, 2023	Jun 23, 2023	Entrada Therapeutics, Inc.	CFO	Sell	7.5	-17,500	-38.50%	✓	$262.6K
Mar 1, 2023	Mar 3, 2023	Entrada Therapeutics, Inc.	CFO	Sell	91.3	+25,648	155.36%	✓	$30K
Dec 8, 2022	Dec 12, 2022	Entrada Therapeutics, Inc.	CFO	Sell	15.0	-4,550	-21.61%	✓	$86.2K
Dec 2, 2022	Dec 6, 2022	Entrada Therapeutics, Inc.	CFO	Sell	28.8	-3,110	-8.61%	✓	$56.6K
Nov 16, 2022	Nov 18, 2022	Entrada Therapeutics, Inc.	CFO	Sell	50.0	-200	-1.20%	✓	$3.6K
Aug 24, 2022	Aug 26, 2022	Entrada Therapeutics, Inc.	CFO	Sell	10.0	-4,669	-29.82%	✓	$64.4K
Aug 19, 2022	Aug 23, 2022	Entrada Therapeutics, Inc.	CFO	Sell	20.0	-11,655	-19.96%	✓	$152.4K
Aug 16, 2022	Aug 18, 2022	Entrada Therapeutics, Inc.	CFO	Sell	52.5	-600	-0.97%	✓	$7.8K